DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 10,820
+20 (0.19%)
At close: Jun 10, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 189.53 billion as of June 10, 2026. Its market cap has decreased by -28.58% in one year.
Market Cap
189.53B
Enterprise Value
285.33B
Revenue
143.42B
Ranking
n/a
PE Ratio
104.58
Stock Price
10,820.00
Market Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 189.53B, an increase of 1,109.65%. That is a compound annual growth rate of 11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 189.18B | -38.04% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 302.48B |
| NOVAREX | 239.97B |
| CellBion | 225.84B |
| Vivozon Pharmaceutical | 191.62B |
| High Tech Pharm | 146.95B |
| GC WellBeing | 143.29B |
| PHARMARESEARCH BIO | 136.50B |
| Kyung Dong Pharmaceutical | 130.80B |